Skip to content
Screener

CapEx at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$555K-98.3%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$24K-93.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$1.2M-30.6%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$0-100%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$675K+22,400%
Regenxbio logo
RegenxbioRGNX
$760K+94.4%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Cash flows from investing activities
Proceeds on maturity of debt securities384,981213,763
Investments in debt securities(232,550)(120,205)
Purchases of property, plant, and equipment(612)(386)
Net cash generated from investing activities151,81993,172
Cash flows from financing activities
Proceeds from follow-on public offering of ordinary shares, net of issuance costs242,68180,511
Proceeds from issuance of ordinary shares related to employee stock options and purchase plans6,985203

Item 1.Financial Statements

FAQ

What is uniQure's capex?
uniQure (QURE) reported capex of $472K in Q2 2026.
How has uniQure's capex changed year-over-year?
uniQure's capex increased by 81.5% year-over-year, from $260K to $472K.
What is the long-term trend for uniQure's capex?
Over 3 years (2021 to 2024), uniQure's capex has grown at a -42.2% compound annual growth rate (CAGR), from $17.44M to $3.37M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about uniQure's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude